Skip to content

Search

Food and nutrition

Discover essential insights on food and nutrition for Type 1 Diabetes, from carb counting to meal planning.

Pump Comparison tool

Pump Comparison tool . This easy-to-use updated comparison tool is designed to help you pick the right device for your family.

Be involved

Find out how to participate in our research and community groups.

Clinical Trials

We are in a new era of T1D care. We can now identify and provide care for people across a spectrum of T1D, from early-stage T1D to symptomatic insulin requiring T1D (Stage 3 and Stage 4). And for the first time since the discovery of insulin over 100 years ago, Australia has approved a new therapy, Teplizumab.

A community-led, trauma-informed psychosocial intervention to improve health outcomes of children and young people with Type-1 diabetes

T1D can be a traumatic diagnosis for children and young people, and often involves strict adherence to painful treatments, comorbid mental health conditions, and shortened life expectancy.

DiabHQ

The DiabHQ Patient Portal app is now available to WA children and families living with Type 1 diabetes.

Childhood-onset type 1 diabetes in Western Australia: An update on incidence and temporal trends from 2001 to 2022

To determine the incidence and incidence trends over 2001-2022 of childhood-onset type 1 diabetes (T1D) in Western Australia and assess the impact of the COVID-19 pandemic.

Impact of Missing Data on the Accuracy of Glucose Metrics from Continuous Glucose Monitoring Assessed Over a 2-Week Period

To explore the impact of missing data on the accuracy of continuous glucose monitoring (CGM) metrics collected for a 2-week period in a clinical trial.

Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: Data from the Australasian Diabetes Data Network registry

Competing challenges in adolescence and young adulthood can distract from optimal type 1 diabetes (T1D) self-management, and increase risks of premature morbidity and mortality. There are limited data mapping the glycemic control of people with T1D in this age group, across Australasia.